<unk> 's primary use in medicine is in the management of the symptoms of schizophrenia. It has been used as both a monotherapy and adjunctive therapy (in case of treatment-resistance) in schizophrenia. It has also been used in the treatment of dysthymia. There is evidence, although low quality, that<unk>  could accelerate antidepressant response in patients with major depressive disorder. There is also evidence of its efficacy in treating panic disorder.<unk>  is indicated for the treatment of vertigo in some countries. In Japan,<unk>  is both approved as a treatment for schizophrenia and for major depressive disorder (low dose).
Sulpiride
Buspirone
Dapoxetine
Bupropion
Vortioxetine
Electroconvulsive therapy
Atomoxetine
Edivoxetine